載入中
HKSEHealthcareDrug Manufacturers - Specialty & Generic
最新資料
HK$1.92
HK$0.00 · 0.00%
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
最新資料
HK$1.92
HK$0.00 · 0.00%
盤中時間採用HKT。市場資料可能有所延遲。
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
日內區間
目前HK$1.92
52週區間
目前HK$1.92
盤中時間採用HKT。市場資料可能有所延遲。
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
日內區間
目前HK$1.92
52週區間
目前HK$1.92
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CNY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 9.43億 CNY | 11.85億 CNY | 9.61億 CNY | 9.92億 CNY | 8.21億 CNY |
| 銷貨成本 | 2.26億 CNY | 2.91億 CNY | 2.64億 CNY | 2.71億 CNY | 2.43億 CNY |
| 毛利 | 7.17億 CNY | 8.94億 CNY | 6.98億 CNY | 7.21億 CNY | 5.78億 CNY |
| 研究與開發 | 392.9萬 CNY | 3241.8萬 CNY | 1707.3萬 CNY | 642萬 CNY | 2228.5萬 CNY |
| 銷售、一般及管理費用 | 4.1億 CNY | 4.73億 CNY | 3.61億 CNY | 3.58億 CNY | 3.65億 CNY |
| 營業費用 | 4.14億 CNY | 5.05億 CNY | 3.78億 CNY | 3.64億 CNY | 3.87億 CNY |
| 利息收入 | 2264.6萬 CNY | 2524.9萬 CNY | 2412.6萬 CNY | 1655.3萬 CNY | 1534.6萬 CNY |
| 利息支出 | 1438.4萬 CNY | 1536.3萬 CNY | 1069.9萬 CNY | 1029.4萬 CNY | 797.5萬 CNY |
| 折舊和攤銷 | 3384萬 CNY | 3642.7萬 CNY | 3903.3萬 CNY | 3864.4萬 CNY | 3697.5萬 CNY |
| 營業利益 | 3.03億 CNY | 3.89億 CNY | 3.49億 CNY | 3.57億 CNY | 1.91億 CNY |
| 淨利 | 2.51億 CNY | 3.19億 CNY | 2.5億 CNY | 2.81億 CNY | 1.88億 CNY |
公司資料更新於 2026年10月9日。
年度分割調整後的每股現金分配。
HK$0.50
2025年（完整年度）+733.3% 自從 2021
2026年（部分年度）：HK$0.34
HK$0.06
2,021
HK$0.18
2,022
HK$0.36
2,023
HK$0.60
2,024
HK$0.50
2,025
HK$0.34
2,026*
* 在現有股息歷史記錄中，該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年6月16日 | HK$0.34Annual | 2026年6月17日 | 2026年6月26日 |
股息 | 2025年6月16日 | HK$0.50Annual | 2025年6月17日 | 2025年6月26日 |
股息 | 2024年6月14日 | HK$0.60Annual | 2024年6月17日 | 2024年6月26日 |
股息 | 2023年6月16日 | HK$0.36Annual | 2023年6月19日 | 2023年6月30日 |
股息 | 2022年5月25日 | HK$0.18Annual | 2022年5月26日 | 2022年6月13日 |
股息 | 2021年6月16日 | HK$0.06Annual | 2021年6月17日 | 2021年6月30日 |
除息 2026年6月16日
HK$0.34
Annual
2026年6月17日登記 · 支付日 2026年6月26日
除息 2025年6月16日
HK$0.50
Annual
2025年6月17日登記 · 支付日 2025年6月26日
除息 2024年6月14日
HK$0.60
Annual
2024年6月17日登記 · 支付日 2024年6月26日
除息 2023年6月16日
HK$0.36
Annual
2023年6月19日登記 · 支付日 2023年6月30日
除息 2022年5月25日
HK$0.18
Annual
2022年5月26日登記 · 支付日 2022年6月13日
除息 2021年6月16日
HK$0.06
Annual
2021年6月17日登記 · 支付日 2021年6月30日
報告持有此股票曝險的交易所交易基金。
Dimensional - Emerging Markets Core Equity 2 ETFDFEM
Dimensional World ex U.S. Core Equity 2 ETFDFAX
Dimensional Emerging Markets Sustainability Core 1 ETFDFSEAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
